A new spectrophotometric method for the determination of serum glutamic oxalacetic transaminase (SCOT) is described which uses standardized technics and prepackaged reagents. A study was made of this new method in three laboratories and was compared with the routine methods, using identical serum specimens. The new procedure gave good reproducibility and precision. In all methods studied there was evidence of failure of linearity of response at the two highest activity levels examined.
in three laboratories. The ease of the technic involved and use of a prepackaged reagent recommend the new method for use in small laboratories.
Materials and Methods
To Table 3 were derived from a general form of the analysis for variance (5) in which all the differences among duplicates jei' day were combined to provide a within-day standard deviation. The same analysis estimated the variation attributable to differences from day to day. The two estimates were combined (6) to provide the day-to-day standard deviation. Figure  3 shows the absorbance change with time for three humanserum samples analyzed by the method described above. Figure  4 shows the effect of analyzing the same set of frozen samples immediately after thawing and then again 4 hr later.
Discussion
The results in Table 1 activity at the two highest levels of activity (Samples H and I). Dilution of the samples had been arranged so that there would be the same absolute increase in activity between serially lettered samples-ie, the increase in activity between B and C should he the same number of units as that between A and B, and so on. Since no sample was devoid of SOOT activity, the plot in Fig 1 does not extend through the origin.
The results of the analyses by the alternative methods (Table 2 and Fig 2) show good agreement between all methods up to the level of activity represented by Sample E. Beyond this level there is fair correspondence between the data derived from the two modified Karmen (2) methods (Laboratories A and C), whereas the Reitman-Frankel with increasing enzyme activity of the data from Laboratory U is better than that of any other method in this study. The slope of the response found in Laboratory A appears to be divided into two parts with a discontinuity at the level of SGOT activity in Sample E, the slope decreasing beyond this point. All values for the two Karmen modifications are higher than those obtained with the method described above. It is possible that this difference is an apparent one only, and is related to the use of the Henry temperature correction factors (2) to correct values from 37#{176} to 32#{176} ill this study where a nonhuman enzyme is employed.
The reagent used in the new method described al)ove showed no endogenous oxidation of reduced NAD in the absence of serum. Reagents for the other methods were not checked for absorbauuce change in the absence of enzyme.
The variance analysis ( 
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Summary
The 
